$41.27 -0.35 (-0.84%) Neurocrine Biosciences Inc - NASDAQ

Jan. 20, 2017 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 41.27
Trade Time: Jan 20 04:00 PM Eastern Daylight Time
Change: -0.35 (-0.84%)
Prev Close: 41.62
Open: 41.60
Bid: 41.26
Ask: 41.27
  1. Morning Call For Wednesday, Jan. 18

    TalkMarkets | Jan. 18, 2017 | 08:00AM EST
  2. Neurocrine Med Failure, Jazz Pharma Generic Rival OK Sends Both Down

    Investors Business Daily | Jan. 17, 2017 | 17:28PM EST
  3. Battleground: Alnylam Plunges After Revusiran Pulled, But Some See Opportunity

    TalkMarkets | Oct. 6, 2016 | 19:50PM EST
  4. Icahn School Of Medicine At Mount Sanai Files Complaint Against Neurocrine Sciences For Breach Of Contract - 8-K Filings

    Benzinga | Dec. 2, 2015 | 17:07PM EST
  5. Neurocrine moves up on trial

    IBD | Oct. 8, 2015 | 17:43PM EST
  6. Neurocrine Tardive Dyskinesia Drug Hits, Stock Jumps

    IBD | Oct. 8, 2015 | 10:33AM EST
  7. Stock Futures Down, But Not Much; Domino's Dives, EMC Advances

    IBD | Oct. 8, 2015 | 08:03AM EST
  8. Teva's Auspex Buyout Pays, But Mylan Bid Hits Snag

    IBD | Jun. 16, 2015 | 14:39PM EST
  9. NEUROCRINE BIOSCIENCES

    IBD | Jun. 8, 2015 | 18:01PM EST
  10. Stocks Hitting 52-Week Highs

    Benzinga | Jan. 15, 2015 | 10:25AM EST
  11. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

    Benzinga | Jan. 13, 2015 | 11:34AM EST
  12. AbbVie Stock Down After Guidance, Downgrade

    IBD | Jan. 9, 2015 | 11:49AM EST
  13. Mid-Morning Market Update: Markets Jump; Family Dollar Profit Misses Estimates

    Benzinga | Jan. 8, 2015 | 11:39AM EST
  14. Benzinga's Volume Movers

    Benzinga | Jan. 8, 2015 | 10:33AM EST
  15. Stocks Hitting 52-Week Highs

    Benzinga | Jan. 8, 2015 | 10:22AM EST
Trading Center